SMTL ID : 3hr1.1

Discovery of novel inhibitors of PDE10A

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.53 Å

Oligo State

monomer

Ligands

2 x SO4: SULFATE ION(Non-functional Binders)

SO4.1: 2 residues within 4Å: Chain A: R.106 Ligands: SO4.2 1 PLIP interactions: 1 interactions with chain A Salt bridges: A:R.106 SO4.2: 3 residues within 4Å: Chain A: R.106, R.154 Ligands: SO4.1 2 PLIP interactions: 2 interactions with chain A Salt bridges: A:R.106, A:R.154

1 x PF9: 2-{[4-(1-methyl-4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy]methyl}quinoline(Non-covalent)

PF9.3: 15 residues within 4Å: Chain A: Y.110, L.261, S.263, V.264, I.278, Y.279, F.282, P.298, M.299, K.304, E.307, V.308, G.311, Q.312, F.315 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:I.278, A:Y.279, A:F.282, A:P.298, A:M.299, A:E.307, A:V.308, A:F.315, A:F.315 Hydrogen bonds: A:Q.312

1 x ZN: ZINC ION(Non-covalent)

ZN.4: 5 residues within 4Å: Chain A: H.115, H.149, D.150, D.260 Ligands: MG.5 5 PLIP interactions: 4 interactions with chain A, 1 Ligand-Water interactions Metal complexes: A:H.115, A:H.149, A:D.150, A:D.260, H2O.5

1 x MG: MAGNESIUM ION(Non-covalent)

MG.5: 2 residues within 4Å: Chain A: D.150 Ligands: ZN.4 6 PLIP interactions: 1 interactions with chain A, 5 Ligand-Water interactions Metal complexes: A:D.150, H2O.1, H2O.1, H2O.1, H2O.16, H2O.16

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Verhoest, P.R. et al., Discovery of a Novel Class of Phosphodiesterase 10A Inhibitors and Identification of Clinical Candidate 2-[4-(1-Methyl-4-pyridin-4-yl-1H-pyrazol-3-yl)-phenoxymethyl]-quinoline (PF-2545920) for the Treatment of Schizophrenia. J.Med.Chem. (2009)

Release Date

2009-08-04

Peptides

cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A

Related Entries With Identical Sequence